InvestorsHub Logo
Followers 45
Posts 4605
Boards Moderated 0
Alias Born 07/19/2006

Re: vinmantoo post# 2968

Wednesday, 05/15/2024 2:31:12 PM

Wednesday, May 15, 2024 2:31:12 PM

Post# of 3019
I think the panoramic trial is powered that they should be able to show efficacy on outcomes like hospitalization even with event rates much lower now in a more immune experienced population
If I were a pharma I would want to see the ensitrelvir data and then decide on 235 bc at this point you are talking only a few months (NIH is running the study so it’s not going to be suppressed long like epic-Sr
NIH of course could choose to fund 235 too if the data do suggest it might be better on efficacy than ensitrelvir
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News